4//SEC Filing
LAZARUS ROCHELLE B 4
Accession 0001104659-22-071136
CIK 0001821825other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 7:34 PM ET
Size
7.5 KB
Accession
0001104659-22-071136
Insider Transaction Report
Form 4
LAZARUS ROCHELLE B
Director
Transactions
- Award
Phantom Stock
2022-06-10$35.46/sh+5,640$199,994→ 14,638 total→ Common Stock (5,640 underlying)
Holdings
- 458
Common Stock
- 175(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]The number of shares of Organon & Co. ("Organon") common stock previously reported has been adjusted based on the finalization of certain calculations in connection with the separation of Organon from Merck & Co., Inc.
- [F2]Each phantom stock unit is an economic equivalent of one share of Organon common stock, or 1-for-1.
- [F3]Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.
- [F4]Holdings include phantom stock acquired in dividend reinvestment transactions on September 13, 2021, December 16, 2021 and March 17, 2022.
Documents
Issuer
Organon & Co.
CIK 0001821825
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001082206
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 7:34 PM ET
- Size
- 7.5 KB